AMDL retains SGI as investor relations advisor

Strategic Growth International (SGI) will assist the company in establishing a stronger understanding of the investment opportunity AMDL represents while increasing the company’s awareness across global investment communities.

Gary Dreher, CEO of AMDL, said: “As we continue building AMDL into a world-class pharmaceutical company we feel strong communications is imperative to our success.

“SGI has a strong reputation with an exceptional team and we’re excited to have them as a partner to communicate our corporate story, the great progress we’re making with new products and technologies in the US, China and other global markets, and most important, how we intend to meet our stated financial targets of doubling annual sales consecutively over the next three years.”